POLB 001 poster to be presented at EHA 2026 Congress

Poolbeg Pharma plc - POLB 001 poster to be presented at EHA 2026 Congress

13 May 2026 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces that it will present data on POLB 001 at the European Hematology Association Congress (“EHA”), taking place 11-14 June 2026 in Stockholm, Sweden. Read more… The post Poolbeg Pharma plc – POLB 001 poster to be presented at EHA 2026 Congress appeared first on Op…

POLB 001 poster to be presented at EHA 2026 Congress

Poolbeg Pharma plc is set to present new data on its drug candidate POLB 001 at the upcoming European Hematology Association Congress 2026, highlighting the treatment’s potential to prevent cancerRead More...